Cannabis holds promise for treating PTSD, yet regulatory barriers have long hindered researchers’ ability to conduct key studies on its safety and effectiveness.

Learn more:
maps.org/2024/11/20/maps-successfully-clears-path-for-cannabis-research-through-fda-formal-dispute/

As featured in Marijuana Moment, the FDA has approved a landmark clinical trial sponsored by MAPS to evaluate smoked cannabis as a treatment for PTSD in Veterans.

marijuanamoment.net/fda-approves-long-awaited-clinical-trial-of-smoked-marijuana-to-treat-ptsd-in-veterans/